CSPC Innovation Pharmaceutical Co Ltd Class A (300765.SZ) stock: key figures, P/E, revenue and dividend

Consumer Staples · Packaged Foods & Meats · China · ISIN CNE100003K04

Price
43.32 CNY
Market cap
60.85 bn CNY
P/E (2025)
–
P/S (2025)
28.34
Dividend yield
0.00 %
Net margin
-11.23 %
Return on equity (ROE)
-8.63 %
Return on assets (ROA)
-3.84 %

CSPC Innovation Pharmaceutical Co Ltd Class A financials

Fiscal year20242025
Revenue1.98 bn CNY2.15 bn CNY
Gross profit825.52 m CNY687.73 m CNY
Operating income-218.34 m CNY-625.82 m CNY
EBIT-214.52 m CNY-625.82 m CNY
Net income53.73 m CNY-241.13 m CNY
Diluted EPS – continuing operations0.04 CNY-0.17 CNY

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About CSPC Innovation Pharmaceutical Co Ltd Class A

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 19.10.2026. Details in the risk notice.

CSPC Innovation Pharmaceutical Co Ltd Class A stock (300765.SZ): P/E, revenue, dividend | finmetric